HUP0302842A2 - Az 1-[6-klór-5-(trifluor-metil)-2-piridinil]-piperazin-hidroklorid kristályalakjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents

Az 1-[6-klór-5-(trifluor-metil)-2-piridinil]-piperazin-hidroklorid kristályalakjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0302842A2
HUP0302842A2 HU0302842A HUP0302842A HUP0302842A2 HU P0302842 A2 HUP0302842 A2 HU P0302842A2 HU 0302842 A HU0302842 A HU 0302842A HU P0302842 A HUP0302842 A HU P0302842A HU P0302842 A2 HUP0302842 A2 HU P0302842A2
Authority
HU
Hungary
Prior art keywords
pyridinyl
trifluoromethyl
chloro
piperazine hydrochloride
crystal forms
Prior art date
Application number
HU0302842A
Other languages
English (en)
Inventor
P. Carlier
P. J. C. M. Hoof
J. C. J. Muyrers
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUP0302842A2 publication Critical patent/HUP0302842A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3403—Needle locating or guiding means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4887—Locating particular structures in or on the body
    • A61B5/489—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3403—Needle locating or guiding means
    • A61B2017/3405—Needle locating or guiding means using mechanical guide means
    • A61B2017/3409—Needle locating or guiding means using mechanical guide means including needle or instrument drives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3403—Needle locating or guiding means
    • A61B2017/3413—Needle locating or guiding means guided by ultrasound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/44—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

A találmány tárgyát az (I) képletű 1-[6-klór-5-(trifluor-metil)-2-piridinil]- piperazin hidroklorid új A és B kristályalakjai, akristályalakok előállítási eljárása, és a B kristályalakot tartalmazógyógyszerkészítmények képezik. A tiszta B kristályalakú 1-[6-klór-5-(trifluor-metil)-2-piridinil]- piperazin hidrokloridot tartalmazógyógyszerkészítmények a depresszió, szorongás, elhízás, vagy vizeletvisszatartási rendellenesség kezelésében alkalmazható. Ó
HU0302842A 2000-10-13 2001-10-09 Az 1-[6-klór-5-(trifluor-metil)-2-piridinil]-piperazin-hidroklorid kristályalakjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények HUP0302842A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203528 2000-10-13
PCT/EP2001/011714 WO2002030902A1 (en) 2000-10-13 2001-10-09 Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride

Publications (1)

Publication Number Publication Date
HUP0302842A2 true HUP0302842A2 (hu) 2003-12-29

Family

ID=8172124

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302842A HUP0302842A2 (hu) 2000-10-13 2001-10-09 Az 1-[6-klór-5-(trifluor-metil)-2-piridinil]-piperazin-hidroklorid kristályalakjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények

Country Status (20)

Country Link
US (1) US20040038985A1 (hu)
EP (1) EP1326837A1 (hu)
JP (1) JP2004512282A (hu)
KR (1) KR20030060906A (hu)
CN (1) CN1469863A (hu)
AU (1) AU2002220614A1 (hu)
BR (1) BR0114609A (hu)
CA (1) CA2425540A1 (hu)
EC (1) ECSP034549A (hu)
HR (1) HRP20030246A2 (hu)
HU (1) HUP0302842A2 (hu)
IL (1) IL154982A0 (hu)
IS (1) IS6758A (hu)
MX (1) MXPA03003233A (hu)
NO (1) NO20031698D0 (hu)
PL (1) PL366055A1 (hu)
RU (1) RU2003113536A (hu)
SK (1) SK4332003A3 (hu)
WO (1) WO2002030902A1 (hu)
ZA (1) ZA200302520B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008004945A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab Novel crystalline forms i and ii
WO2008004944A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab Novel crystalline form ii
CZ303950B6 (cs) * 2011-12-12 2013-07-10 Masarykova Univerzita Zpusob prípravy 1-(pyridin-4-yl)piperazinu a jeho 1,1-dialkyl-1-ium derivátu
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2061953T3 (es) * 1988-11-24 1994-12-16 Akzo Nv Un procedimiento para preparar una composicion farmaceutica.
WO1998033504A1 (en) * 1997-02-03 1998-08-06 Akzo Nobel N.V. Treatment of urinary incontinence

Also Published As

Publication number Publication date
IL154982A0 (en) 2003-10-31
CN1469863A (zh) 2004-01-21
SK4332003A3 (en) 2003-10-07
MXPA03003233A (es) 2003-09-10
ZA200302520B (en) 2004-06-30
AU2002220614A1 (en) 2002-04-22
NO20031698D0 (no) 2003-04-11
CA2425540A1 (en) 2002-04-18
BR0114609A (pt) 2003-12-23
WO2002030902A1 (en) 2002-04-18
JP2004512282A (ja) 2004-04-22
ECSP034549A (es) 2003-05-26
HRP20030246A2 (en) 2003-06-30
PL366055A1 (en) 2005-01-24
KR20030060906A (ko) 2003-07-16
US20040038985A1 (en) 2004-02-26
RU2003113536A (ru) 2004-11-10
EP1326837A1 (en) 2003-07-16
WO2002030902A8 (en) 2004-02-26
IS6758A (is) 2003-03-27

Similar Documents

Publication Publication Date Title
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
NO20023037D0 (no) Nye piperidin- og piperazinderivater
HUP0301447A2 (hu) Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
HUP0203325A2 (hu) Biciklusos aminosavak, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0301512A2 (hu) Gyomor-bél csatornában fellépő kötőszöveti váz tumorok kezelése
HUP0402422A2 (hu) Deuterizált szubsztituált pirazolil-benzolszulfonamid-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
HUP0400782A2 (hu) Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
HUP0401605A2 (hu) Szembetegségek kezelésére szolgáló integrin gátlók
PA8529501A1 (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7."
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
IS6394A (is) Lyfjablanda sem inniheldur solmítriptan
BRPI0411936A (pt) composto, processo para a sua preparação, composição farmacêutica que comprende o mesmo, utilização de um composto, métodos para o tratamento e profilaxia de distúrbios do sistema nervoso central, alimentares e obesidade
HUP0204520A2 (en) Pharmaceutical composition containing esmolol and process for its preparation
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
HUP0300972A2 (hu) Gatifloxacin-pentahidrát
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
HUP0302842A2 (hu) Az 1-[6-klór-5-(trifluor-metil)-2-piridinil]-piperazin-hidroklorid kristályalakjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0301082A2 (hu) Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk
NZ535611A (en) Pharmaceutical composition of a PDE4 or a PDE3/4 inhibitor and a histamine receptor antagonist
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
SE0001916D0 (sv) Novel formulation
HUP0004461A2 (hu) Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények